Our research has demonstrated that in an inflammation model of colon cancer where mice are treated with the carcinogen AOM and DSS (AOM/DSS), tumor development is enhanced with loss of the AhR and AhR ligands inhibit tumorigenesis in AhR+/+ mice. The gene discussed is AHR; the disease is colonic neoplasm.